Literature DB >> 3980998

Induction of protective immunity against Schistosoma mansoni by a non living vaccine. I. Partial characterization of antigens recognized by antibodies from mice immunized with soluble schistosome extracts.

S L James, E J Pearce, A Sher.   

Abstract

A single intradermal injection of frozen and thawed schistosomula in conjunction with the bacterial adjuvant Mycobacterium bovis strain Bacille Calmette Guerin, Phipps substrain (BCG) induced significant levels of resistance to challenge Schistosoma mansoni infection in C57BL/6 mice. Immunization with the aqueous fraction remaining after 100,000 X G centrifugation of the larval lysate was also protective under these conditions, suggesting that some immunogenic determinants may not be membrane associated. Frozen-thawed cercariae and soluble components of adult worms also protected against challenge infection in these experiments. These observations indicate that soluble immunogens are present in both early and late developmental stages of the parasite, and therefore may be good candidate antigens for an immunochemically defined vaccine against schistosomiasis. Induction of humoral reactivity against soluble or membrane antigens was examined in mice protected against cercarial challenge by prior exposure to frozen-thawed larvae, soluble larval, or soluble adult antigens plus BCG. Animals that were immunized with frozen-thawed larvae produced low but significant levels of antibodies against larval surface antigens when examined by indirect immunofluorescence or by immunoprecipitation of surface-labeled schistosomula. Mice immunized with soluble antigens, however, showed negligible antibody reactivity against surface membrane antigens. Because mice immunized with soluble antigens were resistant to challenge infection, these results strongly suggest that anti-surface membrane reactivity is not required in the mechanism of protective immunity in this model. Sera from mice immunized with either total freeze-thaw larval lysate or soluble schistosome extracts all showed strong reactivity against soluble antigens, as detected by ELISA. Western blot analysis showed these antisera to react with a restricted number of high m.w. antigens that were present both in schistosomula and in adult worms. These antigens are therefore likely to play a major role in the development of resistance in this model as immunogens and/or as targets of protective immune response.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3980998

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Interleukin-12 as an adjuvant for an antischistosome vaccine consisting of adult worm antigens: protection of rats from cercarial challenge.

Authors:  R D Bungiro; M Goldberg; P K Suri; P M Knopf
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Protection against experimental Schistosoma mansoni schistosomiasis achieved by immunization with schistosomula released products antigens (SRP-A): role of IgE antibodies.

Authors:  M Damonneville; C Auriault; C Verwaerde; A Delanoye; R Pierce; A Capron
Journal:  Clin Exp Immunol       Date:  1986-08       Impact factor: 4.330

3.  Induction of resistance to Schistosoma mansoni infection in mice by purified parasite paramyosin.

Authors:  T P Flanigan; C H King; R R Lett; J Nanduri; A A Mahmoud
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

4.  Effect of cholera toxin on vaccine-induced immunity and infection in murine schistosomiasis mansoni.

Authors:  A A Akhiani; L A Nilsson; O Ouchterlony
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

5.  Cloning and characterization of Taenia saginata paramyosin cDNA.

Authors:  Elizabeth Ferrer; Eva Moyano; Laura Benitez; Luis Miguel González; Denise Bryce; Mildred Foster-Cuevas; Iris Dávila; Maria Milagros Cortéz; Leslie J S Harrison; R Michael E Parkhouse; Teresa Gárate
Journal:  Parasitol Res       Date:  2003-07-25       Impact factor: 2.289

6.  Induction of protective immunity against Schistosoma mansoni by vaccination with schistosome paramyosin (Sm97), a nonsurface parasite antigen.

Authors:  E J Pearce; S L James; S Hieny; D E Lanar; A Sher
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

7.  What's in SWAP? Abundance of the principal constituents in a soluble extract of Schistosoma mansoni revealed by shotgun proteomics.

Authors:  Leandro Xavier Neves; Ananda Lima Sanson; R Alan Wilson; William Castro-Borges
Journal:  Parasit Vectors       Date:  2015-06-19       Impact factor: 3.876

8.  Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni.

Authors:  E J Pearce; P Caspar; J M Grzych; F A Lewis; A Sher
Journal:  J Exp Med       Date:  1991-01-01       Impact factor: 14.307

Review 9.  Schistosome Vaccine Adjuvants in Preclinical and Clinical Research.

Authors:  Rachel Stephenson; Hong You; Donald P McManus; Istvan Toth
Journal:  Vaccines (Basel)       Date:  2014-09-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.